Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:FCITNYSEARCA:PINNYSE:SDRNYSE:STJ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFCITFirst Citrus Bancorporation$47.82$47.82$25.00▼$50.00N/AN/A1,382 shsN/APINInvesco India ETF$27.03-0.3%$26.47$23.07▼$31.17$236.78M0.7150,066 shs28,052 shsSDRSandRidge Mississippian Trust II$0.13$0.20▼$1.12$6.37M1.14172,872 shs434,700 shsSTJSt Jude Medical$80.82$0.00$48.83▼$84.00N/AN/A8.54 million shsN/AThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFCITFirst Citrus Bancorporation0.00%0.00%0.00%0.00%0.00%PINInvesco India ETF0.00%+0.04%+1.46%+14.78%-8.97%SDRSandRidge Mississippian Trust II0.00%0.00%0.00%0.00%0.00%STJSt Jude Medical0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFCITFirst Citrus BancorporationN/AN/AN/AN/AN/AN/AN/AN/APINInvesco India ETFN/AN/AN/AN/AN/AN/AN/AN/ASDRSandRidge Mississippian Trust IIN/AN/AN/AN/AN/AN/AN/AN/ASTJSt Jude MedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFCITFirst Citrus Bancorporation 0.00N/AN/AN/APINInvesco India ETF 0.00N/AN/AN/ASDRSandRidge Mississippian Trust II 0.00N/AN/AN/ASTJSt Jude Medical 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFCITFirst Citrus BancorporationN/AN/AN/AN/AN/AN/APINInvesco India ETFN/AN/AN/AN/AN/AN/ASDRSandRidge Mississippian Trust II$14.64M0.00N/A1.11$0.85 per share0.00STJSt Jude MedicalN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFCITFirst Citrus BancorporationN/AN/A0.00∞N/AN/AN/AN/AN/APINInvesco India ETFN/AN/A25.88∞N/AN/AN/AN/AN/ASDRSandRidge Mississippian Trust II$10.32MN/A1.28N/AN/A66.85%21.99%21.99%N/ASTJSt Jude MedicalN/A$5.8713.77∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFCITFirst Citrus BancorporationN/AN/AN/AN/AN/APINInvesco India ETF$2.188.07%N/AN/AN/ASDRSandRidge Mississippian Trust II$0.0522.12%N/AN/AN/ASTJSt Jude Medical$1.241.53%N/A21.12%N/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFCITFirst Citrus BancorporationN/APINInvesco India ETF40.83%SDRSandRidge Mississippian Trust II0.98%STJSt Jude Medical82.73%Insider OwnershipCompanyInsider OwnershipFCITFirst Citrus BancorporationN/APINInvesco India ETFN/ASDRSandRidge Mississippian Trust IIN/ASTJSt Jude Medical4.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFCITFirst Citrus BancorporationN/AN/AN/ANot OptionablePINInvesco India ETFN/A8.76 millionN/ANot OptionableSDRSandRidge Mississippian Trust IIN/A49.73 millionN/AOptionableSTJSt Jude MedicalN/AN/AN/AOptionablePIN, FCIT, SDR, and STJ HeadlinesRecent News About These CompaniesSt. Jude begins interior buildout of new 15-story outpatient clinic buildingMay 28, 2025 | bizjournals.com'It's just amazing what they do': St. Jude treats the entire family, not just the patientMay 21, 2025 | msn.comHow St. Jude’s medical social workers help parents navigate child’s diagnosisMay 15, 2025 | msn.comFamily shares experience at St. Jude Children’s Research HospitalMay 10, 2025 | wbko.comWFighting Sickle Cell: How St. Jude and Donors Gave Avery a New Lease on LifeApril 29, 2025 | msn.comOne Step at a Time: How St. Jude and Supporters Helped Arielle Walk AgainApril 29, 2025 | msn.comSt. Jude Rock and Roll Music City marathon marks 25th anniversary this weekendApril 26, 2025 | newschannel5.comNTopeka Dream Home helps St. Jude patients across the U.S.April 24, 2025 | msn.comLocal companies donate materials, labor for St. Jude Dream Home GivewayMarch 28, 2025 | msn.comA St. Jude superhero—this doctor has dedicated her life to treating cancer patientsMarch 22, 2025 | msn.comLocal representative fighting for St. Jude medical care in CharlestonMarch 18, 2025 | msn.com'St. Jude for pets': Decatur vet launching nonprofit research hospital to study diseases affecting humans and animalsMarch 12, 2025 | msn.comSt. Jude, UT, Vanderbilt push to keep NIH fundingFebruary 20, 2025 | dailymemphian.comDProposed federal-funding cuts could come at a cost for St. Jude, UTHSCFebruary 12, 2025 | dailymemphian.comDCould NIH funding cut affect St. Jude Children's Research Hospital? Here's what we knowFebruary 11, 2025 | msn.comNIH cuts could hurt research at St. Jude, UTFebruary 11, 2025 | msn.comSt. Jude creates new leadership roleJanuary 24, 2025 | beckershospitalreview.comBEvidence still under review for suspects in 2023 shooting death of St. Jude doctorJanuary 16, 2025 | wreg.comWOklahoma Family Bakes For A Cause To Help St. Jude Children's HospitalDecember 24, 2024 | newson6.comNSt. Jude names executive vice president and chief administrative officerDecember 11, 2024 | msn.comNew MarketBeat Followers Over TimeTop HeadlinesView All Headlines3 Stocks Hitting All-Time Highs With More Room to RunBy Dan Schmidt | June 27, 2025View 3 Stocks Hitting All-Time Highs With More Room to RunThese 3 Stocks Could Be Back in Play Before You Know ItBy Gabriel Osorio-Mazilli | June 10, 2025View These 3 Stocks Could Be Back in Play Before You Know ItSuper Micro Computer Stock: 2 Levels Smart Money Is WatchingBy Gabriel Osorio-Mazilli | June 13, 2025View Super Micro Computer Stock: 2 Levels Smart Money Is WatchingNike Stock: The Mother of All Comebacks Might Have Just BegunBy Sam Quirke | June 27, 2025View Nike Stock: The Mother of All Comebacks Might Have Just BegunMicrosoft Stock Holds Steady as AI Drives Workforce ShiftBy Chris Markoch | June 23, 2025View Microsoft Stock Holds Steady as AI Drives Workforce ShiftPIN, FCIT, SDR, and STJ Company DescriptionsFirst Citrus Bancorporation OTCMKTS:FCIT$47.82 0.00 (0.00%) As of 01/13/2023As of January 3, 2023, First Citrus Bancorporation, Inc. was acquired by DFCU Financial. First Citrus Bank, a $670 million commercial bank, was established in 1999 and is headquartered in Tampa. Ranked as one of the Top 100 Community Banks in 2021 by American Banker and named Top 5 SBA Lender in Tampa Bay for 2020 by the SBA. First Citrus Bank was selected as the Tampa Bay Chamber of Commerce 2019 Small Business of the Year and ranked as one of the Top 25 Commercial Loan Producers in the Nation by the magazine Independent Banker. It serves businesses and individuals through a range of tailored financial solutions specializing in personal and business banking services with six locations throughout Tampa Bay. First Citrus Bank enhances vibrancy throughout Tampa Bay by helping families become more financially secure and businesses economically successful. For additional information, please visit http://www.firstcitrus.com.Invesco India ETF NYSEARCA:PIN$27.03 -0.08 (-0.30%) As of 04:10 PM EasternPowerShares India Portfolio (the Fund) is based on the Indus India Index (Index). The Fund seeks to achieve its investment objective by investing substantially all of its assets in a wholly-owned subsidiary located in the Republic of Mauritius (the Subsidiary), which in turn invests at least 90% of its total assets in securities of Indian companies that consists of the Index, as well as American depositary receipts(ADR) and global depositary receipts (GDR) based on the securities in the Index. The Index is designed to represent the segment of the Indian equity markets. The Funds sectors allocations include consumers discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, materials and telecommunication services. Invesco PowerShares Capital Management LLC serves as investment adviser the Fund.SandRidge Mississippian Trust II NYSE:SDRSandRidge Mississippian Trust II holds royalty interests in oil and natural gas properties. The company's properties are located in the Mississippian formation in Alfalfa, Grant, Kay, Noble, and Woods counties in northern Oklahoma and Barber; and Comanche, Harper, and Sumner counties in southern Kansas. As of December 31, 2018, its properties consisted of royalty interests in the initial wells and 173 additional wells. The company was founded in 2011 and is based in Houston, Texas.St Jude Medical NYSE:STJSt. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company's product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.